Latest Hemodialysis News
Soluble ferric pyrophosphate is given to hemodialysis patients via dialysate.
Investigators found that dialysis patients with serum calcium levels of 10.2 mg/dL or greater had increased risks of premature death.
Higher magnesium levels in hemodialysis patients with high phosphorus levels were associated with decreased cardiovascular mortality.
Boiling in water and stewing in an oil-water mixture were found to reduce phosphorus levels significantly in various foods.
The frequency of visits to physicians and advanced practitioners by hemodialysis patients had no significant effect on their graft or arteriovenous fistula survival.
A substantial minority of surviving patients also developed long-term dependence on dialysis.
Osteoporosis is significantly associated with an elevated likelihood of coronary artery disease, congestive heart failure, and stroke.
The dietary intake tool has acceptable reliability and validity for African-American patients with low literacy undergoing dialysis.
Pill burden found to be significantly less when compared with patients receiving in-center hemodialysis and peritoneal dialysis.
In the first few months of hemodialysis, one additional provider visit per month increased the probability of AV fistula or graft surgery by nearly 5%.
Use of these agents is associated with a much lower incidence of hypercalcemia compared with the use of calcium carbonate or calcium acetate.
In adjusted analyses, serum phosphorus levels independently predicted glucose disposal rate.
New finding on vitamin B6 is the opposite of what investigators hypothesized on patients with anemia.
IV iron in anemia hemodialysis patients hospitalized for bacterial infections found not to worsen outcomes.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Prostate Cancer Active Surveillance Outcomes Vary by Disease Risk
- High BMI a Plus for Some Metastatic Kidney Cancer Patients
- Statins May Prolong Life in Patients with Advanced Kidney Cancer
- Adjuvant Kidney Cancer Drugs Fail to Improve Outcomes
- Statins Plus ADT After Prostate Cancer Radiotherapy Ups Survival